A compact VEGF signature associated with distant metastases and poor outcomes1 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA 2 Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA 3 Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA 4 Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA 5 Department of Pathology, Stanford University Medical Center, Stanford, CA 94035, USA 6 Section of Hematology/Oncology, Department of Medicine, Committees on Genetics and Cancer Biology, University of Chicago, South Maryland Avenue, Chicago, IL 60637-1463, USA
BMC Medicine 2009, 7:9doi:10.1186/1741-7015-7-9
Additional filesAdditional file 1: Supplementary table. Summary of GEO submission of 202 microarrays used in this paper and clinical data of the patients in this study. Format: XLS Size: 71KB Download file This file can be viewed with: Microsoft Excel Viewer Additional file 2: Figure S1. The complete cluster diagram of all 146 patients using the 1195 gene. MetScore-associated gene list. Format: PDF Size: 692KB Download file This file can be viewed with: Adobe Acrobat Reader Additional file 3: Figure S2. Univariate Kaplan-Meier survival plots for patients stratified using the VEGF profile based upon rank order expression on the A-B) UNC training data set, C-D) NKI test data set, E-F) Bhattacharjee et al [29] lung carcinoma data set, and G-H) Nutt et al [30] glioblastoma data set. Format: PDF Size: 284KB Download file This file can be viewed with: Adobe Acrobat Reader |




on Google Scholar








author email
corresponding author email